I believe they "investigated" an alleged improper grant of stock options a couple of years ago, which went nowhere. Most likely a hedgie fed them that one then, and this one now. Standard manipulation practice. It's all designed for negative PR, not for substance or for an actual lawsuit.
It's unfortunate that I can only "ignore" the threads that you start. But at least that reduces the wasted time having to read your posts somewhat, Schneider.
L'Oreal milestone payment for the bioprinted skin collaboration, in combination with an update on progress of development and perhaps a timeline on commercialization. Can't predict when. Or possibly similar developments re Merck's disease model collaboration. Or, a healthy increase in assay revenue in the next quarterly report.
Good call. And, aside from the humanitarian concerns, I would think that the direct comparison to SOC in the same study could make it more likely to result in accelerated approval, if either the AXAL efficacy is better or it is equivalent with a better safety profile.
Correct math but brokers likely have higher than a 30% maintenance requirement, and margin is based on the entire account, i.e. other positions as well. Also, many obviously shorted well below 4.
No, the amazing science that will revolutionize oncology, and the undervalued, manipulated share price, is what keeps people's interest.
You and your basher buddies seem to suffer the delusion that longs here might give up. Based on what? Continual validation of the science and FDA progress on multiple indications? Nothing else matters. That is why you are both wasting your time, under a dozen aliases.
Tex, there were 10 - 12 trades (buys) of Jan $17.50 calls totaling 1,033 contracts.
have seen healthy call trading. Thanks, Dan!
Actually, the Phase 2 results for Alzheimers were negatively spun, but were actually quite good in terms of the mono treatment. People don't realize that simple lack of progression of Alzheimers is a very good result, which is why they are moving to Phase 3.
Probably jobless in a legitimate job sense. I meant the employer that pays him per bashing post.
He likes to have his money confiscated. Makes him feel like a conscientious and caring person.
Alzheimers drug did not fail. Actually, the results were very good, better than the SOC. The disappointing aspect of the results came from a combo regimen of the AVXL drug AND the SOC, not the mono AVXL drug. Odd. However, today's news pertains to evidence of efficacy for Parkinsons also.